Bexson Biomedical Announces Participation in the Jeffries Innovation in Mental Health Summit

SANTA BARBARA, Calif., Sept. 8, 2022 /PRNewswire/ -- Bexson Biomedical, Inc., a biopharmaceutical company focused on disrupting the $189 billion small molecule injectable market and enabling home health solutions, today announced that the Company's management will be participating in the...

Click to view original post